Medivie Therapeutic (Israel) Today
| MDVI Stock | ILA 35.50 2.00 5.97% |
Performance0 of 100
| Odds Of DistressLess than 43
|
Medivie Therapeutic is trading at 35.50 as of the 30th of November 2024, a 5.97 percent increase since the beginning of the trading day. The stock's open price was 33.5. Medivie Therapeutic has about a 43 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Medivie Therapeutic are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Medivie Therapeutic Limited develops and markets dental devices. Medivie Therapeutic Limited was founded in 2012 and is based in Hemel Hempstead, the United Kingdom. MEDIVIE THERP is traded on Tel Aviv Stock Exchange in Israel. The company has 2.88 M outstanding shares. More on Medivie Therapeutic
Moving together with Medivie Stock
Moving against Medivie Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Medivie Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Medivie Therapeutic's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Medivie Therapeutic or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Itai Hecht |
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Medivie Therapeutic (MDVI) is traded on Tel Aviv Stock Exchange in Israel and employs 11 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.32 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medivie Therapeutic's market, we take the total number of its shares issued and multiply it by Medivie Therapeutic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medivie Therapeutic operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 2.88 M outstanding shares.
Medivie Therapeutic has accumulated about 4.15 M in cash with (3.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.44.
Check Medivie Therapeutic Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Medivie Therapeutic is 4.32 Billion. Medivie Therapeutic secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 72.29 % of Medivie Therapeutic outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Medivie Ownership Details
Medivie Therapeutic Risk Profiles
Although Medivie Therapeutic's alpha and beta are two of the key measurements used to evaluate Medivie Therapeutic's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.72 | |||
| Standard Deviation | 4.56 | |||
| Variance | 20.83 | |||
| Risk Adjusted Performance | (0.11) |
Medivie Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medivie Therapeutic without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Other Information on Investing in Medivie Stock
Medivie Therapeutic financial ratios help investors to determine whether Medivie Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medivie with respect to the benefits of owning Medivie Therapeutic security.